Roche Holding Ltd. (NASDAQ:RHHBY) has received a consensus rating of “Hold” from the twelve brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and four have given a buy recommendation to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $38.00.
Several research analysts have recently commented on the company. UBS AG downgraded Roche Holding from a “buy” rating to a “neutral” rating in a research note on Thursday, July 6th. Cowen and Company set a $38.00 target price on Roche Holding and gave the stock a “buy” rating in a research note on Monday, August 14th. Societe Generale downgraded Roche Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 30th. BNP Paribas reiterated a “neutral” rating on shares of Roche Holding in a research note on Tuesday, June 20th. Finally, Morgan Stanley reiterated an “equal weight” rating on shares of Roche Holding in a research note on Wednesday, July 26th.
COPYRIGHT VIOLATION WARNING: This article was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://ledgergazette.com/2017/09/13/roche-holding-ltd-rhhby-given-consensus-recommendation-of-hold-by-brokerages.html.
Several hedge funds and other institutional investors have recently modified their holdings of RHHBY. Edmp Inc. bought a new position in shares of Roche Holding during the 2nd quarter worth approximately $207,000. Delaney Dennis R lifted its holdings in Roche Holding by 1.8% during the 1st quarter. Delaney Dennis R now owns 7,625 shares of the company’s stock worth $244,000 after purchasing an additional 135 shares during the last quarter. Griffin Asset Management Inc. acquired a new stake in Roche Holding during the 2nd quarter worth approximately $334,000. Elefante Mark B lifted its holdings in Roche Holding by 9.9% during the 2nd quarter. Elefante Mark B now owns 11,135 shares of the company’s stock worth $355,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Moloney Securities Asset Management LLC lifted its holdings in Roche Holding by 26.4% during the 2nd quarter. Moloney Securities Asset Management LLC now owns 12,084 shares of the company’s stock worth $385,000 after purchasing an additional 2,524 shares during the last quarter.
Roche Holding (NASDAQ:RHHBY) traded up 0.51% during midday trading on Wednesday, reaching $31.81. The company had a trading volume of 905,662 shares. The company has a market cap of $217.14 billion and a PE ratio of 21.74. The company’s 50-day moving average is $31.67 and its 200 day moving average is $32.20. Roche Holding has a 52-week low of $25.25 and a 52-week high of $36.82.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.